Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT.
Slavin
S
S
Naparstek
E
E
Nagler
A
A
Kapelushnik
Y
Y
Ackerstein
A
A
Or
R
R
D016026:Bone Marrow Transplantation; D006801:Humans; D016219:Immunotherapy, Adoptive; D007938:Leukemia / Q000628:therapy*; D017710:Lymphocyte Transfusion; D012008:Recurrence